Skip to content

Evaluation of AL Prediction for Rectal Cancer

Evaluation of a Machine Learning Based Anastomotic Leakage Prediction Model After Anterior Resection for Rectal cancer-a Multicenter, Prospective, Randomized Controlled Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05610904
Enrollment
418
Registered
2022-11-09
Start date
2022-12-10
Completion date
2025-10-10
Last updated
2022-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anastomotic Leak Rectum

Keywords

Anastomotic Leak, rectal cancer, machine learning

Brief summary

Anastomotic leakage is one of the most serious postoperative complications of low rectal cancer, with an incidence of 3%-21%. The occurrence of anastomotic leakage is related to many factors, and the occurrence of anastomotic leakage can be predicted by building a prediction model. Most of the anastomotic leakage prediction models constructed in the past are nomograms, which have limitations in the fitting of model creation. In the previous study, the center took the lead in building a random forest anastomotic leakage prediction model based on machine learning. This study intends to prospectively enroll patients with rectal cancer undergoing anterior abdominal resection and use their clinical data to prospectively verify the efficacy of the anastomotic leakage prediction model, and further improve and promote the prediction model.

Interventions

DIAGNOSTIC_TESTPrediction model evaluation

a machine learning based anastomotic leakage prediction model

Sponsors

Changhai Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Patients aged 18-75 years 2. Adenocarcinoma confirmed by pathology 3. Colonoscopy or imaging examination confirmed that the distance between the lower edge of the tumor and the anal edge was less than or equal to 12cm 4. Preoperative imaging diagnosis was cTxNxM0 5. No local complications (no obstruction, incomplete obstruction, no massive active bleeding, no perforation, abscess formation, and no invasion of adjacent organs) 6. The hematopoietic functions of heart, lung, liver, kidney and bone marrow meet the requirements of surgery and anesthesia 7. Voluntarily sign the informed consent form

Exclusion criteria

1. Previous history of malignant tumor 2. Simultaneous multiple primary colorectal cancer 3. Previous multiple abdominal and pelvic surgeries or extensive abdominal adhesions 4. Patients with intestinal obstruction, intestinal perforation, intestinal bleeding, etc., requiring emergency surgery 5. Patients with familial adenomatous polyposis and active inflammatory bowel disease 6. A history of severe mental illness 7. pregnant or lactating women 8. Patients with uncontrolled infection before operation 9. The investigator did not consider the patient to be eligible for the trial

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of stoma implementation1 months after surgeryAccuracy of stoma implementation: the number of anastomotic leakage patients with stoma and none anastomotic leakage patients without stoma to the number of total patients.

Secondary

MeasureTime frame
Sensitivity and specificity in the prediction of anastomotic leakage1 months after surgery
Grade C leakage rate1 months after surgery
Preventive stoma rate1 months after surgery
Rate of stoma reverse3-6 months after surgery

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026